Skip to main content
02/09/2020 - 09:35

PharmAust subsidiary Epichem in waste-to-fuels tilt

02/09/2020 - 09:35

Bookmark

Save articles for future reference.

PharmAust subsidiary Epichem has entered into a joint venture deal to develop a “disruptive” waste-to-fuels technology using biomass and feedstock. Under the 50:50 agreement, medicinal and synthetic chemistry group Epichem and new JV partner Obsidian Minerals will set up the Perren company with the aim of developing and commercialising the biomass/feedstock oxidative hydrothermal dissolution chemical process that can turn waste into fuels.

X